Pharming Group NV (PHAR)
12.59
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
12.59
0.00 (0.00%)
After-Hours: 17:38
Pharming Group Profit Margin (Quarterly) : -7.20% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -7.20% |
| December 31, 2025 | 4.98% |
| September 30, 2025 | 7.71% |
| June 30, 2025 | 4.94% |
| March 31, 2025 | -18.82% |
| December 31, 2024 | 3.99% |
| September 30, 2024 | -1.38% |
| June 30, 2024 | -1.62% |
| March 31, 2024 | -22.39% |
| December 31, 2023 | -3.33% |
| September 30, 2023 | 5.20% |
| June 30, 2023 | 2.40% |
| March 31, 2023 | -28.70% |
| December 31, 2022 | -26.78% |
| September 30, 2022 | 16.78% |
| June 30, 2022 | 31.39% |
| March 31, 2022 | 7.42% |
| December 31, 2021 | 3.91% |
| September 30, 2021 | -0.79% |
| June 30, 2021 | 11.73% |
| March 31, 2021 | 19.56% |
| December 31, 2020 | 14.59% |
| September 30, 2020 | 16.16% |
| June 30, 2020 | 24.72% |
| March 31, 2020 | 17.10% |
| Date | Value |
|---|---|
| December 31, 2019 | 26.58% |
| September 30, 2019 | 23.03% |
| June 30, 2019 | 16.05% |
| March 31, 2019 | 19.13% |
| December 31, 2018 | 30.16% |
| September 30, 2018 | 13.81% |
| June 30, 2018 | 10.10% |
| March 31, 2018 | 18.62% |
| December 31, 2017 | -128.4% |
| September 30, 2017 | -28.72% |
| June 30, 2017 | -161.1% |
| March 31, 2017 | -37.18% |
| December 31, 2016 | -98.80% |
| September 30, 2016 | -108.5% |
| June 30, 2016 | -109.4% |
| March 31, 2016 | -152.9% |
| December 31, 2015 | -173.1% |
| September 30, 2015 | -74.24% |
| June 30, 2015 | -62.49% |
| March 31, 2015 | -74.61% |
| December 31, 2014 | 75.56% |
| September 30, 2014 | 97.47% |
| June 30, 2014 | -366.8% |
| March 31, 2014 | -1.13K% |
| December 31, 2013 | -452.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ProQR Therapeutics NV | -658.3% |
| NewAmsterdam Pharma Co. NV | -1.59K% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alkermes Plc | -16.92% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.86% |
| Return on Assets | 2.62% |
| Return on Invested Capital | 3.25% |
| Gross Profit Margin (Quarterly) | 90.83% |
| Operating Margin (Quarterly) | 3.47% |
| Return on Net Operating Assets | 4.45% |